{"id":"W4389221984","doi":"10.1182/blood-2023-174750","title":"Acalabrutinib ± Obinutuzumab Vs Obinutuzumab + Chlorambucil in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-up of Elevate-TN","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Chlorambucil; Obinutuzumab; Internal medicine; Medicine; Hazard ratio; Neutropenia; Gastroenterology; Chronic lymphocytic leukemia; Leukemia; Chemotherapy; Confidence interval; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006679972,0.0006488765,0.001440509,0.0008588358,0.0001270824,0.00004800656,0.0005433566,0.0005717669,0.0004787326],"category_scores_gemma":[0.0006281272,0.0005772201,0.0004913658,0.002571923,0.0003846921,0.0001949478,0.000332024,0.0004983724,0.001659824],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.2727005,"about_ca_system_score_gemma":0.1212434,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006892182,"about_ca_topic_score_gemma":0.0006317876,"domain_scores_codex":[0.9946043,0.0001645571,0.001130972,0.001116628,0.001289372,0.001694165],"domain_scores_gemma":[0.9969418,0.0005294699,0.0002627694,0.001524185,0.0002636476,0.0004781266],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.09322027,0.01115934,0.06712522,0.03497847,0.02874088,0.08871092,0.05664646,0.03519905,0.3929417,0.01530553,0.07829752,0.0976746],"study_design_scores_gemma":[0.6677617,0.008789432,0.006849461,0.00219289,0.001618566,0.001281357,0.001882395,0.06229541,0.2345538,0.0005496378,0.01064174,0.001583628],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920332,0.001110797,0.000003444611,0.00009005285,0.000391231,0.001612657,0.00008178532,0.0004159634,0.004260899],"genre_scores_gemma":[0.9862023,0.001774589,0.0001171047,0.00006856779,0.0004554919,0.0003130393,0.0002496315,0.0001669757,0.01065233],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5745414,"threshold_uncertainty_score":0.999721,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0275422638931106,"score_gpt":0.2925937077638187,"score_spread":0.2650514438707081,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}